000 | 01918 a2200613 4500 | ||
---|---|---|---|
005 | 20250516183220.0 | ||
264 | 0 | _c20140926 | |
008 | 201409s 0 0 eng d | ||
022 | _a1399-3046 | ||
024 | 7 |
_a10.1111/petr.12196 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKasahara, Mureo | |
245 | 0 | 0 |
_aLiving donor liver transplantation for pediatric patients with metabolic disorders: the Japanese multicenter registry. _h[electronic resource] |
260 |
_bPediatric transplantation _cFeb 2014 |
||
300 |
_a6-15 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHepatolenticular Degeneration _xtherapy |
650 | 0 | 4 | _aHeterozygote |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunosuppression Therapy |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aJapan |
650 | 0 | 4 |
_aLiver Transplantation _xmethods |
650 | 0 | 4 | _aLiving Donors |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMetabolic Diseases _xmortality |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMulticenter Studies as Topic |
650 | 0 | 4 | _aRegistries |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aUrea Cycle Disorders, Inborn _xtherapy |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aSakamoto, Seisuke | |
700 | 1 | _aHorikawa, Reiko | |
700 | 1 | _aKoji, Umeshita | |
700 | 1 | _aMizuta, Koichi | |
700 | 1 | _aShinkai, Masato | |
700 | 1 | _aTakahito, Yagi | |
700 | 1 | _aTaguchi, Tomoaki | |
700 | 1 | _aInomata, Yukihiro | |
700 | 1 | _aUemoto, Shinji | |
700 | 1 | _aTatsuo, Kuroda | |
700 | 1 | _aKato, Shunichi | |
773 | 0 |
_tPediatric transplantation _gvol. 18 _gno. 1 _gp. 6-15 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/petr.12196 _zAvailable from publisher's website |
999 |
_c23315142 _d23315142 |